Trial intelligence / Profile preview

Impact of levothyroxine on erectile function in hypothyroidism

2024-514789-38-00Phase 4Completed

Sponsor
Biobizkaia Health Research Institute
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in hypothyroidism and erectile dysfunction (ED) comparing Levothyroxine monotherapy, Sildenafil monotherapy and Levothyroxine + sildenafil (3 arms). Primary endpoint: Evolution of erectile and sexual function scores. Started Sep 2024; status: completed.

02

Drugs

levothyroxine sodiumsildenafil
03

Conditions

hypothyroidismerectile dysfunction (ED)

Beyond the preview

Go deeper on 2024-514789-38-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-514789-38-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call